Event: Buyback completed
BioMaxima informed that it purchased 180,200 shares in the buyback (4.2% of share capital) for PLN 5.0 million that were dedicated to this purpose and thus the buyback came to an end. Expected impact: Neutral
This report is prepared for the Warsaw Stock Exchange SA within the framework of the Analytical Coverage Support Program 3.0.
Analyst
Sylwia Jaśkiewicz, CFA
Mikołaj Stępień